Anticoagulation in cirrhosis: a new paradigm?
Filippo Leonardi, Nicola De Maria, Erica Villa
Clin Mol Hepatol. 2017;23(1):13-21.   Published online 2017 Mar 14     DOI: https://doi.org/10.3350/cmh.2016.0110
Citations to this article as recorded by Crossref logo
Predictors of bleeding events in acute decompensated heart failure patients with antithrombotic therapy: AURORA study
Shodai Kawanami, Yasuyuki Egami, Hiroki Sugae, Kohei Ukita, Akito Kawamura, Hitoshi Nakamura, Yutaka Matsuhiro, Koji Yasumoto, Masaki Tsuda, Naotaka Okamoto, Yasuharu Matsunaga‐Lee, Masamichi Yano, Masami Nishino, Jun Tanouchi
ESC Heart Failure.2023; 10(2): 1114.     CrossRef
Evolution of care in cirrhosis: Preventing hepatic decompensation through pharmacotherapy
Seohyuk Lee, Saad Saffo
World Journal of Gastroenterology.2023; 29(1): 61.     CrossRef
Emerging Therapeutic Targets for Portal Hypertension
Eric Felli, Yelidousi Nulan, Sonia Selicean, Cong Wang, Jordi Gracia-Sancho, Jaume Bosch
Current Hepatology Reports.2023; 22(1): 51.     CrossRef
Oral Anticoagulation in Patients with Chronic Liver Disease
Raluca S. Costache, Andreea S. Dragomirică, Bogdan E. Gheorghe, Vasile D. Balaban, Silviu M. Stanciu, Mariana Jinga, Daniel O. Costache
Medicina.2023; 59(2): 346.     CrossRef
Advance of New Oral Anticoagulants in the Treatment of Portal Vein Thrombosis in Cir-rhosis
好男 周
Advances in Clinical Medicine.2023; 13(03): 3788.     CrossRef
Optimization of anticoagulant therapy in patients undergoing mechanical heart valve replacement
S. A. Tkachenko, D. A. Astapov, A. V. Bogachev-Prokofiev, A. S. Zalesov, A. N. Pivkin, A. G. Makaev, Kh. A. Agaeva, R. M. Sharifulin
Fundamental and Clinical Medicine.2023; 8(3): 131.     CrossRef
Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis
Haonan Zhou, Mingdong Wu, Shixiong Yu, Han Xia, Wu Yu, Kai Huang, Yikuan Chen
BMC Gastroenterology.2023;[Epub]     CrossRef
mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency
T. Winans, Z. Oaks, G. Choudhary, A. Patel, N. Huang, T. Faludi, D. Krakko, J. Nolan, J. Lewis, Sarah Blair, Z. Lai, S.K. Landas, F. Middleton, J.M. Asara, S.K. Chung, B. Wyman, P. Azadi, K. Banki, A. Perl
Journal of Autoimmunity.2023; 140: 103112.     CrossRef
Diagnosis and Therapy of Visceral Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline
Katja S. Mühlberg
Hämostaseologie.2023;[Epub]     CrossRef
Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism
Diego Martínez-Urbistondo, Rocío G. de la Garza, Paula Villares-Fernández, Carme Font, Sebastian Schellong, Juan José López-Núñez, Aída Gil-Díaz, María del Carmen Díaz-Pedroche, Jana Hirmerova, Manuel Monreal, MD Adarraga, J Aibar, J Alonso, C Amado, JI A
Internal and Emergency Medicine.2022; 17(3): 725.     CrossRef
Trastornos de la coagulación en cirrosis hepática: artículo de revisión
Esteban González-Domínguez, Diego Córdova, Paula Abad, Eduardo González, Camila González, Juan José Cordero
Hepatología.2022; : 13.     CrossRef
Retrospective evaluation of early thrombosis in transjugular intrahepatic portosystemic polytetrafluoroethylene-coated shunts under 2-day postinterventional heparinization
Holger Goessmann, Verna Schuffenhauer, Arne Kandulski, Kilian Weigand, Ernst-Michael Jung, Wibke Uller, Gregor Scharf, Cristian Stroszczynski, Niklas Verloh
Scientific Reports.2022;[Epub]     CrossRef
Anticoagulation after transjugular intrahepatic portosystemic shunt for portal hypertension: A systematic review and meta analysis
Pan Jiao, Xu-Ying Chen, Hong-Yan Zheng, Jia Qin, Chao Li, Xiao-Lin Zhang
Medicine.2022; 101(26): e29742.     CrossRef
Characteristics of myeloproliferative neoplasm-associated portal hypertension and endoscopic management of variceal bleeding
Xiaoquan Huang, Ming Zhang, Yingjie Ai, Siyu Jiang, Mei Xiao, Lifen Wang, Yourong Jian, Yuzheng Zhuge, Chunqing Zhang, Shiyao Chen
Therapeutic Advances in Chronic Disease.2022; 13: 204062232211256.     CrossRef
Portal Interventions in the Setting of Venous Thrombosis or Occlusion
Aliaksei Salei, Husameddin El Khudari, Benjamin J. McCafferty, Rakesh K. Varma
RadioGraphics.2022; 42(6): 1690.     CrossRef
Localized inhibition of platelets and platelet derived growth factor by a matrix targeted glycan mimetic significantly attenuates liver fibrosis
Harsha Kabra, Tanaya Walimbe, Kate Stuart, Camille Indey, Swati Jalgaonkar, Elvis Ikwa, Taylor Skurnac, Julia Chen, Andrew Woolley, Nicholas M. Snead, Nathan Bachtell, Diana J. Leeming, Morten Karsdal, Glenn Prestwich, Alyssa Panitch, John Paderi
Biomaterials.2021; 269: 120538.     CrossRef
NAFLD and Cardiovascular Diseases: Epidemiological, Mechanistic and Therapeutic Considerations
David Niederseer, Bernhard Wernly, Elmar Aigner, Felix Stickel, Christian Datz
Journal of Clinical Medicine.2021; 10(3): 467.     CrossRef
Safety of direct oral anticoagulants in patients with advanced liver disease
Georg Semmler, Katharina Pomej, David J. M. Bauer, Lorenz Balcar, Benedikt Simbrunner, Teresa Binter, Lukas Hartl, Jeannette Becker, Matthias Pinter, Peter Quehenberger, Michael Trauner, Mattias Mandorfer, Ton Lisman, Thomas Reiberger, Bernhard Scheiner
Liver International.2021; 41(9): 2159.     CrossRef
Evolution of views and modern concepts of the state of the hemostasis system in liver cirrhosis
S. A. Aliyev, E. S. Aliyev
Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery.2021; 26(1): 107.     CrossRef
Portal vein thrombosis associated with high 14-day and 6-week rebleeding in patients after oesophageal variceal band ligation: a retrospective, multicentre, nested case–control study
Zhanjuan Gao, Jingrun Zhao, Xiaofeng Liu, Senlin Li, Minghui Wang, Yanjing Gao
Hepatology International.2021; 15(5): 1183.     CrossRef
Viscoelastic tests in liver disease: where do we stand now?
Alina Buliarca, Adelina Horhat, Tudor Mocan, Rares Craciun, Bogdan Procopet, Zeno Sparchez
World Journal of Gastroenterology.2021; 27(23): 3290.     CrossRef
Heparins have adequate ex vivo anticoagulant effects in hospitalized patients with cirrhosis
Bente P. van den Boom, Fien A. von Meijenfeldt, Jelle Adelmeijer, Lara N. Roberts, William Bernal, Ton Lisman
Journal of Thrombosis and Haemostasis.2021; 19(6): 1472.     CrossRef
Portal vein thrombosis in hepatitis C virus-related cirrhotic patients: Prevalence and clinical characteristics in an Egyptian cohort
Omkolsoum Alhaddad, Maha Elsabaawy, Omar Elshaaraawy, Mohamed Elhalawany, Mohamed Mohamed Houseni, Eman Abdelsameea
Tropical Doctor.2021; 51(3): 314.     CrossRef
Topical Issues in Diagnosis of Coagulopathies and Prevention of Thromboembolic Complications of Atrial Fibrillation in Patients with Liver Cirrhosis
Volodymyr Chernyavsky, Alina Baylo
Family medicine.2021; (5-6): 59.     CrossRef
Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation
Hyun Jeong Kim, Sang Yeol Kim, Suk Pyo Shin, Young Joo Yang, Chang Seok Bang, Gwang Ho Baik, Dong Joon Kim, Young Lim Ham, Eui Yul Choi, Ki Tae Suk
The Korean Journal of Internal Medicine.2020; 35(2): 320.     CrossRef
Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms
Jaejun Lee, Pil Soo Sung, Ki-Seong Eom, Hyun Yang, Soon Kyu Lee, Aung Hlaing Bwa, Angelo Lozada, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clinical and Molecular Hepatology.2020; 26(1): 78.     CrossRef
What's new in portal hypertension?
Ezequiel Mauro, Adrián Gadano
Liver International.2020; 40(S1): 122.     CrossRef
Nationwide cohort study of outcomes of acute myocardial infarction in patients with liver cirrhosis
Victor Chien-Chia Wu, Shao-Wei Chen, An-Hsun Chou, Michael Wu, Pei-Chi Ting, Shang-Hung Chang, Chao-Yung Wang, Ming-Shyan Lin, Kuo-Chun Hung, I-Chang Hsieh, Pao-Hsien Chu, Cheng-Shyong Wu, Yu-Sheng Lin
Medicine.2020; 99(12): e19575.     CrossRef
Novel therapeutics for portal hypertension and fibrosis in chronic liver disease
Sergi Guixé-Muntet, Chang-Peng Zhu, Wei-Fen Xie, Jordi Gracia-Sancho
Pharmacology & Therapeutics.2020; 215: 107626.     CrossRef
New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis
Oana Nicoară-Farcău, Guillem Soy, Marta Magaz, Anna Baiges, Fanny Turon, Angeles Garcia-Criado, Marta Barrufet, Marta Burrel, Virginia Hernández-Gea, Juan Carlos García-Pagán
Seminars in Thrombosis and Hemostasis.2020; 46(06): 673.     CrossRef
Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease
Saro Khemichian, Norah A. Terrault
Seminars in Thrombosis and Hemostasis.2020; 46(06): 682.     CrossRef
Effects of Anticoagulants on Experimental Models of Established Chronic Liver Diseases: A Systematic Review and Meta-Analysis
Rui Zhang, Xiaoquan Huang, Yingyi Jiang, Jian Wang, Shiyao Chen, Alessandro Granito
Canadian Journal of Gastroenterology and Hepatology.2020; 2020: 1.     CrossRef
Хирургическое лечение осложненных форм цирроза печени: современные представления и перспективы (обзор литературы)
Роман Николаевич Канцуров , Наталия Германовна Сапронова , Элеонора Владимировна Светова , Денис Сергеевич Калинин , Дмитрий Вячеславович Стагниев , Михаил Юрьевич Кострыкин
Естественные и Технические Науки.2020; (№11): 169.     CrossRef
Hepatic microcirculation and mechanisms of portal hypertension
Jordi Gracia-Sancho, Giusi Marrone, Anabel Fernández-Iglesias
Nature Reviews Gastroenterology & Hepatology.2019; 16(4): 221.     CrossRef
The multifaceted role of fibrinogen in tissue injury and inflammation
James P. Luyendyk, Jonathan G. Schoenecker, Matthew J. Flick
Blood.2019; 133(6): 511.     CrossRef
Current and future pharmacological therapies for managing cirrhosis and its complications
David Kockerling, Rooshi Nathwani, Roberta Forlano, Pinelopi Manousou, Benjamin H Mullish, Ameet Dhar
World Journal of Gastroenterology.2019; 25(8): 888.     CrossRef
Fibrinolytic Shutdown Is Associated With Intraoperative Thrombosis and Hemorrhage During Visceral Transplant
Yehuda Raveh, Fouad Souki, Joshua Livingstone, Thiago Beduschi, Rodrigo Vianna, Yiliam Rodriguez, Ramona Nicolau-Raducu
Seminars in Cardiothoracic and Vascular Anesthesia.2019; 23(3): 300.     CrossRef
Anticoagulation in Patients with Liver Cirrhosis (Literature Review)
E. S. Eniseeva
Acta Biomedica Scientifica (East Siberian Biomedical Journal).2019; 4(2): 23.     CrossRef
Safety of direct oral anticoagulants in patients with cirrhosis: a systematic review and meta-analysis
K Lapumnuaypol, C DiMaria, T Chiasakul
QJM: An International Journal of Medicine.2019; 112(8): 605.     CrossRef
Efficacy of a strict surveillance policy towards inappropriateness of plasma transfusion
Ivo Beverina, Chiara Novelli, Arianna Gatti, Alessandro Aloni, Chiara Grassi, Stefania Latella, Rita Scalvini, Cinzia Gatti, Bruno Brando
Transfusion and Apheresis Science.2019; 58(4): 423.     CrossRef
Pharmacologic Management of Portal Hypertension
Chalermrat Bunchorntavakul, K. Rajender Reddy
Clinics in Liver Disease.2019; 23(4): 713.     CrossRef
Patients with Heart Failure and Preserved Ejection Fraction Are at Risk of Gastrointestinal Bleeding
Lore Schrutka, Benjamin Seirer, Franz Duca, Christina Binder, Daniel Dalos, Andreas Kammerlander, Stefan Aschauer, Lorenz Koller, Alberto Benazzo, Asan Agibetov, Marianne Gwechenberger, Christian Hengstenberg, Julia Mascherbauer, Diana Bonderman
Journal of Clinical Medicine.2019; 8(8): 1240.     CrossRef
Inherited thrombophilia and portal vein thrombosis in cirrhosis: A systematic review and meta‐analysis
Steven D. Ma, Jennifer Wang, Dmitri Bezinover, Zakiyah Kadry, Patrick G. Northup, Jonathan G. Stine
Research and Practice in Thrombosis and Haemostasis.2019; 3(4): 658.     CrossRef
Liver Diseases and the Hemostasis (Rewiew) Part 1. Non-Cholestatic Diseases of the Liver and Hemostasis
V. I. Reshetnyak, I. V. Maev, T. M. Reshetnyak, S. V. Zhuravel, V. M. Pisarev
General Reanimatology.2019; 15(5): 74.     CrossRef
Fibrinolysis Shutdown Is Associated With Thrombotic and Hemorrhagic Complications and Poorer Outcomes After Liver Transplantation
Ramona Nicolau‐Raducu, Thiago Beduschi, Rodrigo Vianna, Christian Diez, Mahmoud Sleem, Bhavna P. Singh, Georgia Vasileiou, Yehuda Raveh
Liver Transplantation.2019; 25(3): 380.     CrossRef
Role of the blood coagulation cascade in hepatic fibrosis
Asmita Pant, Anna K. Kopec, James P. Luyendyk
American Journal of Physiology-Gastrointestinal and Liver Physiology.2018; 315(2): G171.     CrossRef
Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management
Thomas A. Verbeek, Jonathan G. Stine, Fuat H. Saner, Dmitri Bezinover
Transplantation Direct.2018; 4(11): e403.     CrossRef
Alternatively spliced tissue factor levels are elevated in the plasma of patients with chronic liver diseases
Nathalie I. Caversaccio, Maria D. Reina Caro, Raja Prince, Martin Müller, Clayton S. Lewis, Vladimir Y. Bogdanov, Jean-François Dufour, Anne Angelillo-Scherrer
European Journal of Gastroenterology & Hepatology.2018; 30(12): 1470.     CrossRef
ANTIVIRAL AND ANTICOAGULANT THERAPY IN A POLYMORBID PATIENT WITH CHRONIC VIRAL HEPATITIS C. TACTICS OF MANAGEMENT, FEATURES OF DRUG-DRUG INTERACTIONS
V.A. Volovnikova, E.N. Zinovieva
Juvenis Scientia.2018; (10): 9.     CrossRef
Perioperatives Management bei Patienten mit Leberzirrhose
J. Rädle, C. Mönch
Der Gastroenterologe.2017; 12(6): 464.     CrossRef